# A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.

> **NCT00002349** · NA · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00002349
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-01
- **Primary completion:** 1999-05
- **Final completion:** 1999-05
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002349, "A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00002349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*